Georgia
Participating institutions
- National Center for Tuberculosis and Lung Diseases
Lead investigator
- Nestani Tukvadze, MD, PhD
As of April 2024
Cohort enrollment capacity
- Drug-resistant TB
| Number | Rate per 100,000 population | |
|---|---|---|
| Total TB incidence | 2,200 (1,800 – 2,700) | 60 (48 – 73) |
| HIV-positive TB incidence | 64 (42 – 90) | 1.7 (1.1 – 2.4) |
| MDR/RR-TB incidence | 360 (270 – 440) | 9.5 (7.3 – 12) |
| HIV-negative TB mortality | 67 (51 – 85) | 1.8 (1.4 – 2.3) |
| HIV-positive TB mortality | 20 (13 – 29) | 0.53 (0.34 – 0.77) |